Por: RTTNews Health October 03, 2022
Clene Inc. () and its wholly owned subsidiary biopharmaceutical company Clene Nanomedicine Inc., announced Monday topline study results showing a survival benefit in the Healey ALS Platform trial of CNM-Au8, an investigational gold nanocrystal suspension, in participants with amyotrophic lateral sclerosis (ALS).The primary endpoint of slope of change in ALS Functional Rating Scale Revised (ALSFRS-R) scores adjusted for mortality was not... + full article
WPTV USA Nation October 04, 2022
Imagine being trapped in a paralyzed body. That's how the describes the progression of a neurological disease called ALS, which 31,000 people in the United States are living with.Thankfully, there is hope for a better quality of life thanks to a drug that the Food and Drug... + más
FDA approves ALS drug partly funded by Ice Bucket Challenge | 10 WBNS
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ABC7 USA Health September 30, 2022
, has been approved by the US Food and Drug Administration.The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on Thursday. The oral medication can be taken as a standalone therapy or with other treatments, according to the company, and it has been shown... + más
ALS drug wins FDA approval despite questionable data | ABC News
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
New York Post USA Life September 30, 2022
A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of... + más
ALS drug gets FDA approval despite uncertainty about effectiveness | ABC7
PennLive USA Nation September 30, 2022
WASHINGTON — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
10 WBNS USA Nation September 30, 2022
WASHINGTON — A for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The Food and Drug Administration approved the drug from... + más
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
About iurex | Privacy Policy | Disclaimer |